Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 971712, 15 pages
http://dx.doi.org/10.1155/2013/971712
Research Article

P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells

Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China

Received 17 June 2013; Revised 27 July 2013; Accepted 12 August 2013

Academic Editor: Paul Siu-Po Ip

Copyright © 2013 Xiang-Bao Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Lim and C. W. Zhang, “Molecular events underlying Parkinson's disease: an interwoven tapestry,” Frontiers in Neurology, vol. 4, article 33, 2013. View at Publisher · View at Google Scholar
  2. P. C. Trippier, K. Jansen Labby, D. D. Hawker, J. J. Mataka, and R. B. Silverman, “Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers,” Journal of Medicinal Chemistry, vol. 56, no. 8, pp. 3121–3147, 2013. View at Google Scholar
  3. O. Hwang, “Role of oxidative stress in Parkinson's disease,” Experimental Neurobiology, vol. 22, no. 1, pp. 11–17, 2013. View at Google Scholar
  4. M. H. Yan, X. Wang, and X. Zhu, “Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease,” Free Radical Biology and Medicine, vol. 62, pp. 90–101, 2013. View at Publisher · View at Google Scholar
  5. Y.-C. Lo, Y.-T. Shih, I.-J. Chen, and Y.-C. Wu, “San-Huang-Xie-Xin-Tang protects against activated microglia- and 6-OHDA-induced toxicity in neuronal SH-SY5Y cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 429384, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kumar, I. S. Kim, S. V. More et al., “Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 514095, 13 pages, 2013. View at Publisher · View at Google Scholar
  7. S.-H. Kwon, S.-I. Hong, Y.-H. Jung et al., “Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-κB in SH-SY5Y cells,” Food and Chemical Toxicology, vol. 50, no. 3-4, pp. 797–807, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. F.-C. Luo, S.-D. Wang, L. Qi, J.-Y. Song, T. Lv, and J. Bai, “Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 448–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Xu, W.-F. Chen, and M.-S. Wong, “Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway,” British Journal of Pharmacology, vol. 158, no. 3, pp. 738–748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. H. Kim, K. Song, S. H. Yoon et al., “Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside Re activation of nitric oxide signaling,” Journal of Biological Chemistry, vol. 287, no. 53, pp. 44109–44120, 2012. View at Google Scholar
  11. B. K. Barlow, D. W. Lee, D. A. Cory-Slechta, and L. A. Opanashuk, “Modulation of antioxidant defense systems by the environmental pesticide maneb in dopaminergic cells,” NeuroToxicology, vol. 26, no. 1, pp. 63–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Du, H. Xu, H. Jiang, and J. Xie, “Akt/Nrf2 activated upregulation of heme oxygenase-1 involves in the role of Rg1 against ferrous iron-induced neurotoxicity in SK-N-SH cells,” Neurotoxicity Research, vol. 24, no. 1, pp. 71–79, 2013. View at Google Scholar
  13. S. R. Boston, R. Deshmukh, S. Strome, U. D. Priyakumar, A. D. MacKerell Jr., and P. Shapiro, “Characterization of ERK Docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9,” BMC Cancer, vol. 11, article 7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. B. S. Bowser, S. Alam, and C. Meyers, “Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway,” Journal of Virology, vol. 85, no. 10, pp. 4982–4992, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Li, J. K. Du, L. Y. Zou et al., “Decursin isolated from Angelica gigas Nakai rescues PC12 cells from amyloid beta-protein-induced neurotoxicity through Nrf2-mediated upregulation of Heme oxygenase-1: potential roles of MAPK,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 467245, 14 pages, 2013. View at Publisher · View at Google Scholar
  16. G. B. Sun, X. Sun, M. Wang et al., “Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression,” Toxicology and Applied Pharmacology, vol. 265, no. 2, pp. 229–240, 2012. View at Google Scholar
  17. E. J. Park, Y. M. Kim, S. W. Park et al., “Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264. 7 cells and CLP-induced septic mice,” Food and Chemical Toxicology, vol. 55, pp. 386–395, 2013. View at Google Scholar
  18. J. Xu, M. Xilouri, J. Bruban et al., “Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling,” Neurobiology of Aging, vol. 32, no. 12, pp. 2326.e5–2326.e16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Zoubeidi, A. Zardan, R. M. Wiedmann et al., “Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD,” Cancer Research, vol. 70, no. 6, pp. 2307–2317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Wang, J. Z. Liu, J. X. Hu et al., “ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 539–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Yuan, C. Y. Jiang, H. Xu et al., “Cadmium-induced apoptosis in primary rat cerebral cortical neurons culture is mediated by a calcium signaling pathway,” PLoS ONE, vol. 8, no. 5, Article ID e64330, 2013. View at Google Scholar
  22. R. Andrew, D. G. Watson, S. A. Best, J. M. Midgley, H. Wenlong, and R. K. H. Petty, “The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls,” Neurochemical Research, vol. 18, no. 11, pp. 1175–1177, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Chambers, S. Howard, and P. V. LoGrasso, “Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo,” Journal of Biological Chemistry, vol. 288, no. 2, pp. 1079–1087, 2013. View at Google Scholar
  24. V. Lehmensiek, E.-M. Tan, S. Liebau et al., “Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant α-synucleins related to Parkinson's disease,” Neurochemistry International, vol. 48, no. 5, pp. 329–340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Tobon-Velasco, J. H. Limon-Pacheco, M. Orozco-Ibarra et al., “6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-kappaB factors,” Toxicology, vol. 304, pp. 109–119, 2013. View at Google Scholar
  26. G. Tovilovic, N. Zogovic, V. Soskic et al., “Arylpiperazine-mediated activation of Akt protects SH-SY5Y neuroblastoma cells from 6-hydroxydopamine-induced apoptotic and autophagic death,” Neuropharmacology, vol. 72, pp. 224–235, 2013. View at Google Scholar
  27. N. Sriraksa, J. Wattanathorn, S. Muchimapura, S. Tiamkao, K. Brown, and K. Chaisiwamongkol, “Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 823206, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. Cunha, M. D. Martin-de-Saavedra, A. Romero et al., “Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: involvement of intracellular signaling pathways,” Neuroscience, vol. 238, pp. 185–194, 2013. View at Google Scholar
  29. J.-W. Kim, M.-H. Li, J.-H. Jang et al., “15-Deoxy-Δ12,14-prostaglandin J2 rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2,” Biochemical Pharmacology, vol. 76, no. 11, pp. 1577–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Yang, J. Zha, J. Jockel, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer, “Bad, a heterodimeric partner for Bcl-x(L), and Bcl-2, displaces Bax and promotes cell death,” Cell, vol. 80, no. 2, pp. 285–291, 1995. View at Google Scholar · View at Scopus
  31. A. Bonni, A. Brunet, A. E. West, S. R. Datta, M. A. Takasu, and M. E. Greenberg, “Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms,” Science, vol. 286, no. 5443, pp. 1358–1362, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. M. C. Lawrence, A. Jivan, C. Shao et al., “The roles of MAPKs in disease,” Cell Research, vol. 18, no. 4, pp. 436–442, 2008. View at Publisher · View at Google Scholar · View at Scopus